Best Peptides for Lyme Disease Support

Lyme disease support addresses the complex symptoms associated with Borrelia burgdorferi infection and co-infections from tick-borne pathogens, including persistent inflammation, immune dysregulation, and tissue damage. Research into peptide therapeutics for Lyme disease remains limited, though antimicrobial peptides and immune-modulating sequences are being investigated in preclinical models for their potential to support immune function and reduce inflammatory responses associated with tick-borne illness. Current research focuses on understanding how peptides might complement conventional treatment approaches rather than serve as primary interventions.

Dosing protocols for Lyme disease-related peptide research are not well-established in clinical literature, as this remains an emerging area of investigation. Any exploration of peptide use should occur under appropriate medical supervision, particularly given the complexity of Lyme disease presentation and potential interactions with conventional antimicrobial treatments.